Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|July 5, 2014
CD19 as a molecular target in CNS autoimmunityOlaf Stüve, Clemens Warnke, Krystin Deason, et al.
Journal of Neurology|July 13, 2016
Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 casesRoderick P P W M Maas, Annemarie H G Muller-Hansma, Rianne A J Esselink, et al.
Scientific Reports|March 4, 2024
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damageFabian Boesl, Yasemin Goereci, Finja Schweitzer, et al.
Neurology|September 20, 2013
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosisClemens Warnke, Anne K Mausberg, Mark Stettner, et al.
Journal of Neurology|January 7, 2022
Innovative therapeutic concepts of progressive multifocal leukoencephalopathyNora Möhn, Lea Grote-Levi, Franziska Hopfner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 17, 2010
CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virusClemens Warnke, Vsevolod Smolianov, Thomas Dehmel, et al.
Fluids and Barriers of the CNS|October 28, 2020
Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathyNora Möhn, Yi Luo, Thomas Skripuletz, et al.
Neurological Research and Practice|May 18, 2025
From routine to selective: how updated MRI guidelines reshape gadolinium use in GermanyMarc Pawlitzki, Alexander Stahmann, Niklas Frahm, et al.
Pageof 13